The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Open accessAbstract
The potential use of antisense and siRNA oligonucleotides as therapeutic agents has elicited a great deal of interest. However, a major issue for oligonucleotide-based therapeutics involves effective intracellular delivery of the active molecules. In this Survey and Summary, we review recent reports on delivery strategies, including conjugates of oligonucleotides with various ligands, as well as use of nanocarrier approaches. These are discussed in the context of intracellular trafficking pathways and issues regarding in vivo biodistribution of molecules and nanoparticles. Molecular-sized chemical conjugates and supramolecular nanocarriers each display advantages and disadvantages in terms of effective and nontoxic delivery. Thus, choice of an optimal delivery modality will likely depend on the therapeutic context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
Rab proteins as membrane organizers
Zerial, M., & McBride, H. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052055 · Cited by 3,381
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
(2024) · Pharmacological Reviews · doi:10.1124/pr · Cited by 2,664
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,931
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
The multiple faces of caveolae
Parton, R. G., & Simons, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2122 · Cited by 1,454
Gene silencing in mammals by small interfering RNAs
McManus, M. T., & Sharp, P. A. (2002) · Nature Reviews Genetics · doi:10.1038/nrg908 · Cited by 1,399
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · cited 1×
“Stable nucleic acid lipid particles (SNALPs), a type of liposome, have proven very effective for delivery of siRNA to the liver (169).”
BackgroundOptimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Distinct endocytic pathways regulate TGF-β receptor signalling and turnover
Di Guglielmo, G. M., Le Roy, C., Goodfellow, A. F., & Wrana, J. L. (2003) · Nature Cell Biology · doi:10.1038/ncb975 · Cited by 1,151
Nelson, C. M., & Bissell, M. J. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104315 · Cited by 1,130
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Phagocytosis of Microbes: Complexity in Action
Underhill, D. M., & Ozinsky, A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.103001.114744 · Cited by 1,124
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Antisense technologies: Improvement through novel chemical modifications
Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,006
Rabs and their effectors: achieving specificity in membrane traffic
Grosshans, B. L., Ortiz, D., & Novick, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601617103 · Cited by 1,005
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Peptide-Labeled Near-Infrared Quantum Dots for Imaging Tumor Vasculature in Living Subjects
Cai, W., Shin, D.-W., Chen, K., Gheysens, O., Cao, Q., Wang, S. X., Gambhir, S. S., & Chen, X. (2006) · Nano Letters · doi:10.1021/nl052405t · Cited by 948
P bodies: at the crossroads of post-transcriptional pathways
Eulalio, A., Behm-Ansmant, I., & Izaurralde, E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2080 · Cited by 936
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J. C., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 929
siRNAs: applications in functional genomics and potential as therapeutics
Dorsett, Y., & Tuschl, T. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1345 · Cited by 909
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides
Duchardt, F., Fotin‐Mleczek, M., Schwarz, H., Fischer, R., & Brock, R. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00572.x · Cited by 771
Local Actin Polymerization and Dynamin Recruitment in SV40-Induced Internalization of Caveolae
Pelkmans, L., Püntener, D., & Helenius, A. (2002) · Science · doi:10.1126/science.1069784 · Cited by 720
Transport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Cai, H., Reinisch, K., & Ferro-Novick, S. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.005 · Cited by 685
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703778104 · Cited by 658
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
van Vlerken, L. E., Vyas, T. K., & Amiji, M. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9284-6 · Cited by 645
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
Mechanism of oligonucleotide release from cationic liposomes.
Zelphati, O., & Szoka, F. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11493 · Cited by 634
GUPTA, B., LEVCHENKO, T., & TORCHILIN, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.007 · Cited by 632
Sato, Y., Murase, K., Kato, J., Kobune, M., Sato, T., Kawano, Y., Takimoto, R., Takada, K., Miyanishi, K., Matsunaga, T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1396 · Cited by 609
Greish, K. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701539584 · Cited by 600
Juliano, R. L. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.090401.151133 · Cited by 597
Self-citationAcute cholesterol depletion inhibits clathrin-coated pit budding
Subtil, A., Gaidarov, I., Kobylarz, K., Lampson, M. A., Keen, J. H., & McGraw, T. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6775 · Cited by 578
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Molecular Basis for Target RNA Recognition and Cleavage by Human RISC
Ameres, S. L., Martinez, J., & Schroeder, R. (2007) · Cell · doi:10.1016/j.cell.2007.04.037 · Cited by 559
Dicing and slicing: The core machinery of the RNA interference pathway
Hammond, S. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.079 · Cited by 545
Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
Peer, D., Park, E. J., Morishita, Y., Carman, C. V., & Shimaoka, M. (2008) · Science · doi:10.1126/science.1149859 · Cited by 493
Simeoni, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg385 · Cited by 480
Oishi, M., Nagasaki, Y., Itaka, K., Nishiyama, N., & Kataoka, K. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044941d · Cited by 476
Biodegradable polymers as non-viral carriers for plasmid DNA delivery
Luten, J., van Nostrum, C. F., De Smedt, S. C., & Hennink, W. E. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.028 · Cited by 471
Delivery of bioactive molecules into the cell: the Trojan horse approach
Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469
Nonviral delivery of synthetic siRNAs in vivo
Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464
Specificity, duplex degradation and subcellular localization of antagomirs
Krützfeldt, J., Kuwajima, S., Braich, R., Rajeev, K. G., Pena, J., Tuschl, T., Manoharan, M., & Stoffel, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm024 · Cited by 455
Aptamer mediated siRNA delivery
Chu, T. C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl388 · Cited by 446
Clathrin-independent endocytosis: New insights into caveolae and non-caveolar lipid raft carriers
Kirkham, M., & Parton, R. G. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.06.002 · Cited by 438
ANTISENSE OLIGONUCLEOTIDES: FROM DESIGN TO THERAPEUTIC APPLICATION
Chan, J. H., Lim, S., & Wong, W. F. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04403.x · Cited by 430
Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives
Patel, L. N., Zaro, J. L., & Shen, W.-C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9303-7 · Cited by 425
Progress in antisense technology
Crooke, S. T. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104408 · Cited by 417
Tünnemann, G., Martin, R. M., Haupt, S., Patsch, C., Edenhofer, F., & Cardoso, M. C. (2006) · The FASEB Journal · doi:10.1096/fj.05-5523com · Cited by 402
Targeted Quantum Dot Conjugates for siRNA Delivery
Derfus, A. M., Chen, A. A., Min, D.-H., Ruoslahti, E., & Bhatia, S. N. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060367e · Cited by 395
Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells
Muratovska, A., & Eccles, M. R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01505-9 · Cited by 390
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382
Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells
Chiu, Y.-L., Ali, A., Chu, C.-Y., Cao, H., & Rana, T. M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.06.006 · Cited by 381
Nanogels for Oligonucleotide Delivery to the Brain
Vinogradov, S. V., Batrakova, E. V., & Kabanov, A. V. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034164r · Cited by 377
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
Moschos, S. A., Jones, S. W., Perry, M. M., Williams, A. E., Erjefalt, J. S., Turner, J. J., Barnes, P. J., Sproat, B. S., Gait, M. J., & Lindsay, M. A. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070077d · Cited by 350
RNA interference and chemically modified small interfering RNAs
Manoharan, M. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.10.007 · Cited by 346
PAMAM dendrimers for efficient siRNA delivery and potent gene silencing
Zhou, J., Wu, J., Hafdi, N., Behr, J.-P., Erbacher, P., & Peng, L. (2006) · Chemical Communications · doi:10.1039/b601381c · Cited by 342
Tumor-targeted Delivery of siRNA by Self-assembled Nanoparticles
Li, S.-D., Chen, Y.-C., Hackett, M. J., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300323 · Cited by 333
Delivery of short interfering RNA using endosomolytic cell‐penetrating peptides
Lundberg, P., El‐Andaloussi, S., Sütlü, T., Johansson, H., & Langel, Ü. (2007) · The FASEB Journal · doi:10.1096/fj.06-6502com · Cited by 322
Efficient In Vivo Delivery of siRNA to the Liver by Conjugation of α-Tocopherol
Nishina, K., Unno, T., Uno, Y., Kubodera, T., Kanouchi, T., Mizusawa, H., & Yokota, T. (2008) · Molecular Therapy · doi:10.1038/mt.2008.14 · Cited by 312
Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference
Tan, W. B., Jiang, S., & Zhang, Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.018 · Cited by 295
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
Geary, R. S., Watanabe, T. A., Truong, L., Freier, S., Lesnik, E. A., Sioufi, N. B., Sasmor, H., Manoharan, M., & Levin, A. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38831-7 · Cited by 288
Chemical modification: the key to clinical application of RNA interference?
Corey, D. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33483 · Cited by 285
Peer, D., Zhu, P., Carman, C. V., Lieberman, J., & Shimaoka, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608491104 · Cited by 275
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
Meade, B. R., & Dowdy, S. F. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.004 · Cited by 274
Astriab-Fisher, A., Sergueev, D., Fisher, M., Shaw, B. R., & Juliano, R. L. (2002) · Pharmaceutical Research · doi:10.1023/a:1016136328329 · Cited by 268
Self-citationMeyer, M., Philipp, A., Oskuee, R., Schmidt, C., & Wagner, E. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710344v · Cited by 263
Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study
El-Andaloussi, S., Järver, P., Johansson, H. J., & Langel, Ü. (2007) · Biochemical Journal · doi:10.1042/bj20070507 · Cited by 259
Li, Z.-B., Cai, W., Cao, Q., Chen, K., Wu, Z., He, L., & Chen, X. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.039859 · Cited by 251
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy
Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.669 · Cited by 249
Advantages of liposomal delivery systems for anthracyclines
Allen, T. M., & Martin, F. J. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.001 · Cited by 248
Endothelial Cell Adhesion Molecules and Cancer Progression
Kobayashi, H., Boelte, K., & Lin, P. C. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941032 · Cited by 244
Grzelinski, M., Urban-Klein, B., Martens, T., Lamszus, K., Bakowsky, U., Höbel, S., Czubayko, F., & Aigner, A. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.751 · Cited by 234
Antisense oligonucleotide-based therapeutics for cancer
Dean, N. M., & Bennett, C. F. (2003) · Oncogene · doi:10.1038/sj.onc.1207231 · Cited by 234
Turner, J. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki991 · Cited by 233
Transcription and RNAi in heterochromatic gene silencing
Bühler, M., & Moazed, D. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1315 · Cited by 228
Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting
De Paula, D., Bentley, M. V. L. B., & Mahato, R. I. (2007) · RNA · doi:10.1261/rna.459807 · Cited by 228
TAT Peptide Internalization: Seeking the Mechanism of Entry
Vives, E., Richard, J., Rispal, C., & Lebleu, B. (2003) · Current Protein & Peptide Science · doi:10.2174/1389203033487306 · Cited by 225
Akhtar, S., & Benter, I. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.010 · Cited by 219
RNA interference: the new somatic cell genetics?
Paddison, P. J., & Hannon, G. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00092-2 · Cited by 215
Unsolved Mysteries in Membrane Traffic
Pfeffer, S. R. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.061705.130002 · Cited by 215
Amantana, A., Moulton, H. M., Cate, M. L., Reddy, M. T., Whitehead, T., Hassinger, J. N., Youngblood, D. S., & Iversen, P. L. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070060v · Cited by 213
“Smart” delivery of antisense oligonucleotides by anionic pH-sensitive liposomes
Fattal, E. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.037 · Cited by 211
Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich Peptides
Moulton, H. M., Nelson, M. H., Hatlevig, S. A., Reddy, M. T., & Iversen, P. L. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034221g · Cited by 210
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
Sazani, P., & Kole, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19547 · Cited by 207
Polymer genomics: An insight into pharmacology and toxicology of nanomedicines☆
KABANOV, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.019 · Cited by 204
Sorting Nexins – Unifying Trends and New Perspectives
Carlton, J., Bujny, M., Rutherford, A., & Cullen, P. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00260.x · Cited by 199
Chances and pitfalls of cell penetrating peptides for cellular drug delivery
Tréhin, R., & Merkle, H. P. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.02.018 · Cited by 199
Tat-Conjugated PAMAM Dendrimers as Delivery Agents for Antisense and siRNA Oligonucleotides
Kang, H., DeLong, R., Fisher, M. H., & Juliano, R. L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8330-5 · Cited by 198
Self-citationTherapeutic potential of antisense oligonucleotides as modulators of alternative splicing
Sazani, P., & Kole, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319547 · Cited by 198
Intra-endosomal membrane traffic
van der Goot, F. G., & Gruenberg, J. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.08.003 · Cited by 197
Therapeutic potential for microRNAs
Esau, C. C., & Monia, B. P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.007 · Cited by 195
Veldhoen, S., Laufer, S. D., Trampe, A., & Restle, T. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl941 · Cited by 188
Manoharan, M. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760070849 · Cited by 185
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Durieux, B., Löffler, K., Fechtner, M., Röhl, T., Fisch, G., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302778 · Cited by 183
Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers
Yoo, H. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4225 · Cited by 181
Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway
Aplin, A. E., & Juliano, R. L. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.5.695 · Cited by 180
Self-citationStability of Cell-Penetrating Peptide−Morpholino Oligomer Conjugates in Human Serum and in Cells
Youngblood, D. S., Hatlevig, S. A., Hassinger, J. N., Iversen, P. L., & Moulton, H. M. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060138s · Cited by 179
Improvement through novel chemical modifications
Kurreck, J. (2003) · Cited by 179
Antisense inhibition of P-glycoprotein expression using peptide–oligonucleotide conjugates
Astriab-Fisher, A., Sergueev, D. S., Fisher, M., Ramsay Shaw, B., & Juliano, R. L. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00310-5 · Cited by 172
Self-citationA Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids
El-Andaloussi, S., Johansson, H. J., Holm, T., & Langel, Ü. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300255 · Cited by 170
Chen, H., & Camilli, P. V. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409719102 · Cited by 164
Juliano, R. L., Alahari, S. K., Yoo, H., Kole, R., & Cho, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1011958726518 · Cited by 160
Self-citationEvolving endosomes: how many varieties and why?
Perret, E., Lakkaraju, A., Deborde, S., Schreiner, R. P., & Rodriguez-Boulan, E. J. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.06.008 · Cited by 160
Transendothelial Transport: The Vesicle Controversy
Rippe, B., Rosengren, B.-I., Carlsson, O., & Venturoli, D. (2002) · Journal of Vascular Research · doi:10.1159/000064521 · Cited by 159
Vascular zip codes in angiogenesis and metastasis
Ruoslahti, E. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320397 · Cited by 158
Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide
Abes, S., Turner, J. J., Ivanova, G. D., Owen, D., Williams, D., Arzumanov, A. A., Clair, P., Gait, M. J., & Lebleu, B. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm418 · Cited by 157
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?
Grimm, D., & Kay, M. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci34129 · Cited by 151
Duxbury, M. S., Ashley, S. W., & Whang, E. E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.199 · Cited by 144
Interactions of antisense DNa oliginucletide analogs with phospholid membranes (liposomes)
Akhtar, S., Basu, S., Wickstrom, E., & Juliano, R. L. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5551 · Cited by 142
Self-citationInduction of splice correction by cell‐penetrating peptide nucleic acids
Andaloussi, S. E., Johansson, H. J., Lundberg, P., & Langel, Ü. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.950 · Cited by 141
Reductively Labile PRINT Particles for the Delivery of Doxorubicin to HeLa Cells
Petros, R. A., Ropp, P. A., & DeSimone, J. M. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801436j · Cited by 137
Phospholipid membrane permeability of peptide nucleic acid
Wittung-Stafshede, P. E., Kajanus, J., Edwards, K., Nielsen, P. E., Nordén, B., & Malmström, B. G. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00409-3 · Cited by 137
Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis
Alam, M. R., Dixit, V., Kang, H. M., Li, Z., Chen, X. S., Trejo, J., Fisher, M. H., & Juliano, R. L. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn115 · Cited by 133
Self-citationTurner, J. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki142 · Cited by 132
Latest Development in Drug Discovery on G Protein-coupled Receptors
Publisher, B. S. P. B. S. (2006) · Current Protein and Peptide Science · doi:10.2174/138920306778559403 · Cited by 131
MicroRNAs as Therapeutic Targets
Czech, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmcibr060065 · Cited by 129
Freeman, A. I., & Mayhew, E. G. (1986) · Cancer · doi:10.1002/1097-0142(19860715)58:2+<573::aid-cncr2820581328>3.0.co;2-c · Cited by 128
Wu, R. P., Youngblood, D. S., Hassinger, J. N., Lovejoy, C. E., Nelson, M. H., Iversen, P. L., & Moulton, H. M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm478 · Cited by 124
Cell-penetrating-peptide-based delivery of oligonucleotides: an overview
Abes, R., Arzumanov, A. A., Moulton, H. M., Abes, S., Ivanova, G. D., Iversen, P. L., Gait, M. J., & Lebleu, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350775 · Cited by 122
Tsutsumi, T., Hirayama, F., Uekama, K., & Arima, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.013 · Cited by 121
Efficacy of siRNA Nanocapsules Targeted Against the EWS–Fli1 Oncogene in Ewing Sarcoma
Toub, N., Bertrand, J., Tamaddon, A. M., Elhamess, H., Hillaireau, H., Maksimenko, A., Maccario, J., Malvy, C., Fattal, E., & Couvreur, P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9901-9 · Cited by 106
Hu, J., & Corey, D. R. (2007) · Biochemistry · doi:10.1021/bi700230a · Cited by 102
Delivery Strategies for siRNA-mediated Gene Silencing
Gilmore, I. R., Fox, S. P., Hollins, A. J., et al. (2006) · Current Drug Delivery · doi:10.2174/156720106776359159 · Cited by 99
Corey, D. R. (2006) · Nature Chemical Biology · doi:10.1038/nchembio0107-8 · Cited by 97
Synthetic and Natural Polycations for Gene Therapy: State of the Art and New Perspectives
Tiera, M. J., Winnik, F. M., & Fernandes, J. (2006) · Current Gene Therapy · doi:10.2174/156652306775515510 · Cited by 90
Xu, D., McCarty, D. M., Fernandes, A., Fisher, M. H., Samulski, R. J., & Juliano, R. L. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.019 · Cited by 88
Self-citationBárány-Wallje, E., Gaur, J., Lundberg, P., Langel, Ü., & Gräslund, A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.046 · Cited by 86
Intracellular trafficking of raft/caveolae domains: Insights from integrin signaling
Echarri, A., Muriel, O., & del Pozo, M. Á. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.08.004 · Cited by 83
Armbruster, B. N., & Roth, B. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400030200 · Cited by 81
Inhibition of MDR1 expression with altritol-modified siRNAs
FISHER, M. S., Abramov, M., Aerschot, A. A. V., Xu, D., Juliano, R. L., & Herdewijn, P. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1126 · Cited by 81
Self-citationBcl-2 antisense oligonucleotides: a potential novel strategy for the treatment of breast cancer
Nahta, R. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.016 · Cited by 77
Cesarone, G., Edupuganti, O. P., Chen, C.-P., & Wickstrom, E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070135v · Cited by 77
Pharmaceutical and Biomedical Potential of Surface Engineered Dendrimers
Satija, J., Gupta, U. D., & Jain, N. K. (2007) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v24.i3.20 · Cited by 75
Meyer, M., & Wagner, E. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1062 · Cited by 68
Monomolecular Assembly of siRNA and Poly(ethylene glycol)−Peptide Copolymers
DeRouchey, J. E., Schmidt, C., Walker, G. F., Koch, C. A., Plank, C., Wagner, E., & Rädler, J. O. (2008) · Biomacromolecules · doi:10.1021/bm7011482 · Cited by 68
Cell and Tissue Targeting of Nucleic Acids for Cancer Gene Therapy
Ruß, V., & Wagner, E. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9233-9 · Cited by 63
Abes, S., Moulton, H. M., Turner, J., Clair, P., Richard, J., Iversen, P. L., Gait, M. J., & Lebleu, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350053 · Cited by 62
Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA.
Juliano, R. L. (2005) · PubMed · Cited by 60
Self-citationCarette, J. E., Overmeer, R. M., Schagen, F. H. E., Alemany, R., Barski, O. A., Gerritsen, W. R., & van Beusechem, V. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3530 · Cited by 60
Phosphorothioate‐stimulated uptake of short interfering RNA by human cells
Overhoff, M. G., & Sczakiel, G. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400535 · Cited by 58
Kamashev, D. E., Ng, E., Ebralidse, K. K., & Mirzabekov, A. D. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01153-6 · Cited by 48
Temming, K., Lacombe, M., van der Hoeven, P., Prakash, J., Gonzalo, T., Dijkers, E. C. F., Őrfi, L., Kéri, G., Poelstra, K., Molema, G., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0600158 · Cited by 46
Tian, X., Aruva, M. R., Qin, W., Zhu, W., Sauter, E. R., Thakur, M. L., & Wickstrom, E. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0497923 · Cited by 43
The many futures for cell-penetrating peptides: how soon is now?
Howl, J., Nicholl, I. D., & Jones, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350767 · Cited by 41
Mescalchin, A., Detzer, A., Wecke, M., Overhoff, M. G., Wünsche, W., & Sczakiel, G. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.10.1531 · Cited by 40
Ectopic expression of systemic RNA interference defective protein in embryonic stem cells
Tsang, S. Y., Moore, J. C., van Huizen, R., Chan, C. W. Y., & Li, R. A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.187 · Cited by 33
Wang, L., Prakash, R. K., Stein, C. A., Koehn, R. K., & Ruffner, D. E. (2003) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729003768247637 · Cited by 32
Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis
Serini, G., Napione, L., & Bussolino, F. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282fa745b · Cited by 28
Molecular design and delivery of siRNA
Inoue, A., Sawata, S. Y., & Taira, K. (2006) · Journal of drug targeting · doi:10.1080/10611860600845397 · Cited by 28
Quantitative microscopy reveals 3D organization and kinetics of endocytosis in rat hepatocytes
Marbet, P., Rahner, C., Stieger, B., & Landmann, L. (2006) · Microscopy Research and Technique · doi:10.1002/jemt.20337 · Cited by 21
Szoka, F. C. (2008) · Science · doi:10.1126/science.1154253 · Cited by 20
Cited by
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
Vauthier, C., & Bouchemal, K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9800-3 · Cited by 929
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., & Trent, J. O. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.004 · Cited by 874
Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics
Heitz, F., Morris, M. C., & Divita, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00057.x · Cited by 867
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
Metadata
- Authors
- Juliano, R., Alam, M. R., Dixit, V., & Kang, H.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-23
- Volume
- 36
- Issue
- 12
- Pages
- 4158-4171
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W1994869675
- Cited by
- 429
- References
- 173
- FWCI
- 18.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.